3577 results for «2381»
3577 results
Stable CAD and multivessel disease
20 May 2025 – From EuroPCR 2025
This session delves into the management of stable coronary artery disease (CAD) with multivessel involvement. Learn how clinical and procedural factors influence revascularisation strategies, debate the merits of complete revascularisation, and explore decision-making processes between anatomical and functional approaches through illustrative cases and expert analysis.
Getting started with a renal denervation programme
20 May 2025 – From EuroPCR 2025
Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.
TAVI in patients with a small annulus
20 May 2025 – From EuroPCR 2025
Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.
Strategic decision in stent failure
20 May 2025 – From EuroPCR 2025
Explore strategic decision-making in cases of stent failure in this session presenting complex clinical scenarios. Through detailed case analyses, including challenging left main trifurcation lesions and NSTEMI in the presence of chronic total occlusions, discover treatment approaches and key learnings to optimize patient outcomes.
New evidence for treatment of calcified coronary artery disease
20 May 2025 – From EuroPCR 2025
Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...
How to deal with secondary mitral regurgitation in 2025?
20 May 2025 – From EuroPCR 2025
Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.
Intracoronary value for PCI optimisation
20 May 2025 – From EuroPCR 2025
Optimize your PCI strategies with intracoronary insights in this session highlighting plaque stabilization, coronary stent optimization under pressure, and the critical role of intravascular imaging beyond angiography. Learn management approaches for traumatic coronary artery dissection and explore diagnosis of delayed stent fracture using enhanced stent visualization...
PCR's Got Talent Round 1 - Session 2
20 May 2025 – From EuroPCR 2025
Join the dynamic PCR's Got Talent Round 1 - Session 2 featuring cutting-edge research and innovations in interventional cardiology. Highlights include complex CTO PCI strategies, valve comparisons in TAVI for small annuli, PFO closure outcomes, long-term PCI durability, CT-guided robotic PCI, pacemaker prediction post-TAVI, and much...
Decompensated heart failure: indication and management of mechanical circulatory support
20 May 2025 – From EuroPCR 2025
This session reviews state-of-the-art strategies for managing life-threatening acute heart failure, focusing on indications and management of mechanical circulatory support, including cases like young myocarditis. Learn contemporary approaches for patients after mechanical circulatory support removal through interactive case discussions.
Difficult ACS case management and complication
20 May 2025 – From EuroPCR 2025
Learn expert strategies for managing challenging acute coronary syndrome (ACS) cases and complications. This session covers balloon-uncrossable CTO management in high-risk NSTEMI, iatrogenic coronary perforation during STEMI, spontaneous coronary artery dissection, and complex anterior STEMI interventions with key clinical learnings.
Resilience and continuity of cardiovascular care in times of crises: the RESIL-Card project
20 May 2025 – From EuroPCR 2025
Reflect on cardiovascular care resilience during crises with insights from the RESIL-Card project initiated by the PCR community. This session shares lessons from the pandemic, presents the development of a novel resilience assessment tool, and outlines future timelines to better prepare cardiac care systems for upcoming...
Nurses and allied professionals clinical cases session
20 May 2025 – From EuroPCR 2025
Highlighting the critical role of nurses and allied professionals, this session presents clinical case discussions on managing brachial dissection, rare ACS diagnosis, coronary perforation, and rotablator complications. Emphasis is placed on teamwork and training illustrated by a case of acute transcatheter aortic valve migration to optimize...
Insights into emerging prognostic predictors for patients with coronary artery disease
20 May 2025 – From EuroPCR 2025
Gain insights into emerging prognostic predictors for coronary artery disease patients, including endothelial shear stress as a cardiovascular risk marker, impacts of intravascular imaging stratified by disease pattern, correlations between diastolic blood pressure and SYNTAX score, and long-term wall shear stress risk prediction from the FAME...
Best companion's case for complications for stable coronary artery disease PCI: episode 2
20 May 2025 – From EuroPCR 2025
Examine complex complication cases during stable coronary artery disease PCI with detailed analyses of iatrogenic coronary dissection, procedural challenges, IVUS-guided resolution, and innovative catheter techniques that highlight precision and adaptability in interventional cardiology.
Peripheral artery disease: cutting-edge research and evidence
20 May 2025 – From EuroPCR 2025
Review cutting-edge research and evidence in peripheral artery disease, focusing on IVUS-guided endovascular therapy for femoropopliteal disease, evolving endovascular approaches for Leriche syndrome, predictors of adverse events post-transpedal angioplasty, and multicentre outcomes of distal radial access for radial artery recanalization.
DCB-PCI in de novo lesions
20 May 2025 – From EuroPCR 2025
Evaluate the role of drug-coated balloon (DCB) angioplasty in de novo coronary lesions with a focus on vessel diameter effects, comparisons to drug-eluting stents for small non-complex lesions, management of unstented dissections, high bleeding risk scenarios, and optimal dual antiplatelet therapy durations.
Complex multivessel disease - LIVE Case
21 May 2025 – From EuroPCR 2025
An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...
Which valve is best for my patient?
21 May 2025 – From EuroPCR 2025
This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.
Current DCB practice: from lesion preparation to follow-up
21 May 2025 – From EuroPCR 2025
Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
